Related Experiment Video
Updated: Jun 6, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Financial implications of obesity.
George V Russell1, Christine W Pierce, Loren Nunley
1Department of Orthopaedic Surgery, University of Mississippi Medical Center, Jackson, MS 39216, USA. gvrussell@umc.edu
The Orthopedic Clinics of North America
|November 25, 2010
Summary
The growing obesity epidemic increases healthcare demands and costs for orthopedic surgeons. Addressing reimbursement disparities and inequities in care for obese patients is crucial for the evolving healthcare model.
Area of Science:
- Orthopedics
- Public Health
- Healthcare Economics
Background:
- The global obesity epidemic is escalating, leading to a rise in patients requiring orthopedic care for injuries and chronic conditions.
- Obese and morbidly obese patients present unique challenges in both nonoperative and operative orthopedic treatment, demanding more resources and time.
- Current healthcare systems lack adequate mechanisms to address reimbursement disparities for providers treating this patient population.
Purpose of the Study:
- To highlight the increasing burden of obesity on orthopedic surgery services.
- To identify the need for a revised healthcare model that accommodates the complexities of treating obese patients.
- To advocate for equitable reimbursement and care standards for individuals with obesity.
Main Methods:
- This study is a conceptual analysis and review of the impact of obesity on orthopedic care.
- It synthesizes current trends in obesity prevalence and healthcare resource utilization.
- It examines existing healthcare reimbursement structures in the context of bariatric patient care.
Main Results:
- Obesity significantly increases the complexity and resource requirements for orthopedic interventions.
- There is a notable absence of specific reimbursement frameworks to account for the additional provider time and effort.
- The current healthcare model is ill-equipped to handle the projected increase in demand and associated costs.
Conclusions:
- A systemic approach is necessary to address the financial and logistical challenges posed by the obesity epidemic in orthopedics.
- Collaboration among stakeholders is essential to develop fair reimbursement policies and ensure equitable care for obese patients.
- The healthcare system must adapt to provide comprehensive and adequately compensated care for the growing number of patients with obesity.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:26Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...